Vaccine R&D success rates and development times

Field evaluation of vaccine efficacy.

Orenstein Wa, Bernier Rh, Dondero Tj et al. · PubMed · 1985 · 554 citations

Public Health, Infectious Diseases, Preventive Medicine +17

SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR

MyronM. Levine, D A Herrington, Genevieve Losonsky et al. · The Lancet · 1988 · 324 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children

Emma R. Miller, Paddy Farrington, M. Goldracre et al. · The Lancet · 1993 · 206 citations

Medicine, Infectious Diseases, Pediatrics +16

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

Myron M. Levine, Catterina Ferreccio, Stanley J. Cryz et al. · The Lancet · 1990 · 202 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.

Reinhard Glück, Robert Mischler, Stefan Brantschen et al. · Journal of Clinical Investigation · 1992 · 156 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17